STOCK TITAN

RBC Bearings (RBC) director receives new stock and option awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

RBC Bearings director Steven H. Kaplan reported new equity awards and updated holdings. He received a grant of 344 shares of Common Stock at $0.0000 per share, increasing his direct restricted stock holdings to 1,728 shares, which vest in tranches between 2026 and 2029.

He was also granted options to purchase 647 shares of Common Stock at an exercise price of $565.2200 per share, vesting 1/5 annually from 2027 through 2031. The filing lists multiple additional option grants with exercise prices between $137.4400 and $365.8700, expiring from 2027 to 2032. No open‑market buys or sells were reported; activity reflects compensation-related grants and existing option positions.

Positive

  • None.

Negative

  • None.
Insider Kaplan Steven H.
Role null
Type Security Shares Price Value
Grant/Award Option to Purchase Common Stock 647 $0.00 --
Grant/Award Common Stock 344 $0.00 --
holding Option to Purchase Common Stock -- -- --
holding Option to Purchase Common Stock -- -- --
holding Option to Purchase Common Stock -- -- --
holding Option to Purchase Common Stock -- -- --
holding Option to Purchase Common Stock -- -- --
holding Option to Purchase Common Stock -- -- --
Holdings After Transaction: Option to Purchase Common Stock — 647 shares (Direct, null); Common Stock — 1,728 shares (Direct, null)
Footnotes (1)
  1. Consists of 1,728 shares of restricted stock, which vest according to the following schedule; 400 shares that vest on 6/5/2026; 452 shares 1/2 of which vest on 5/29/2026 and 1/2 vest on 5/29/2027; 532 shares 1/3 of which vest on 5/30/2026, 1/3 vest on 5/30/2027 and 1/3 vest on 5/30/2028; and 344 shares 1/3 of which vest on 5/19/2027, 1/3 vest on 5/19/2028 and 1/3 vest on 5/19/2029. These options to purchase Common Stock are subject to the following vesting schedule - 1/5 vest on 5/19/2027, 1/5 vest on 5/19/2028, 1/5 vest on 5/19/2029, 1/5 vest on 5/19/2030 and 1/5 vest on 5/19/2031. All these options to purchase Common Stock are exerciseable except for 200 options that vest on 6/3/2026. All these options to purchase Common Stock are exerciseable except for 400 options that are subject to the following vesting schedule - 1/2 vest on 6/6/2026 and 1/2 vest on 6/6/2027. All these options to purchase Common Stock are exerciseable except for 600 options that are subject to the following vesting schedule - 1/3 vest on 6/5/2026, 1/3 vest on 6/5/2027 and 1/3 vest on 6/5/2028. All these options to purchase Common Stock are exerciseable except for 779 that are subject to the following vesting schedule - 1/4 vest on 5/29/2026, 1/4 vest on 5/29/2027, 1/4 vest on 5/29/2028 and 1/4 vest on 5/29/2029. These options to purchase Common Stock are subject to the following vesting schedule - 1/5 vest on 5/30/2026, 1/5 vest on 5/30/2027, 1/5 vest on 5/30/2028, 1/5 vest on 5/30/2029 and 1/5 vest on 5/30/2030.
Restricted stock grant 344 shares Common Stock granted at $0.0000 per share
Restricted stock holdings 1,728 shares Restricted Common Stock after grant, vesting 2026–2029
New option grant size 647 shares Options to purchase Common Stock granted
New option exercise price $565.2200 per share Exercise price for 647-share option grant
New option expiration May 19, 2033 Expiration date of 647-share option grant
Other option exercise prices $137.4400–$365.8700 Range of exercise prices for existing options
Existing option sizes 400–1,000 shares Underlying shares per existing option grant
restricted stock financial
"Consists of 1,728 shares of restricted stock, which vest according to the following schedule"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
vesting schedule financial
"which vest according to the following schedule; 400 shares that vest on 6/5/2026"
A vesting schedule is a timeline that determines when someone gains full ownership of certain benefits, such as company stock or retirement contributions. Think of it like earning the right to own a gift gradually over time, rather than receiving it all at once. It matters to investors because it affects when they can fully access or sell these benefits, influencing their financial planning and decision-making.
Option to Purchase Common Stock financial
"These options to purchase Common Stock are subject to the following vesting schedule"
exercise price financial
"exercisePrice": "365.8700""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date": "2033-05-19T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kaplan Steven H.

(Last)(First)(Middle)
11 LINDEN SHORES

(Street)
BRANFORD CONNECTICUT 06405

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
RBC Bearings INC [ RBC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/19/2026A344A$01,728(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Option to Purchase Common Stock$565.2205/19/2026A64705/19/2027(2)05/19/2033Common Stock647$0647D
Option to Purchase Common Stock$137.4406/02/202406/02/2027Common Stock400400D
Option to Purchase Common Stock$199.1606/03/2022(3)06/03/2028Common Stock1,0001,000D
Option to Purchase Common Stock$199.0906/06/2023(4)06/06/2029Common Stock1,0001,000D
Option to Purchase Common Stock$206.1906/05/2024(5)06/05/2030Common Stock1,0001,000D
Option to Purchase Common Stock$287.3705/29/2025(6)05/29/2031Common Stock974974D
Option to Purchase Common Stock$365.8705/30/2026(7)05/30/2032Common Stock962962D
Explanation of Responses:
1. Consists of 1,728 shares of restricted stock, which vest according to the following schedule; 400 shares that vest on 6/5/2026; 452 shares 1/2 of which vest on 5/29/2026 and 1/2 vest on 5/29/2027; 532 shares 1/3 of which vest on 5/30/2026, 1/3 vest on 5/30/2027 and 1/3 vest on 5/30/2028; and 344 shares 1/3 of which vest on 5/19/2027, 1/3 vest on 5/19/2028 and 1/3 vest on 5/19/2029.
2. These options to purchase Common Stock are subject to the following vesting schedule - 1/5 vest on 5/19/2027, 1/5 vest on 5/19/2028, 1/5 vest on 5/19/2029, 1/5 vest on 5/19/2030 and 1/5 vest on 5/19/2031.
3. All these options to purchase Common Stock are exerciseable except for 200 options that vest on 6/3/2026.
4. All these options to purchase Common Stock are exerciseable except for 400 options that are subject to the following vesting schedule - 1/2 vest on 6/6/2026 and 1/2 vest on 6/6/2027.
5. All these options to purchase Common Stock are exerciseable except for 600 options that are subject to the following vesting schedule - 1/3 vest on 6/5/2026, 1/3 vest on 6/5/2027 and 1/3 vest on 6/5/2028.
6. All these options to purchase Common Stock are exerciseable except for 779 that are subject to the following vesting schedule - 1/4 vest on 5/29/2026, 1/4 vest on 5/29/2027, 1/4 vest on 5/29/2028 and 1/4 vest on 5/29/2029.
7. These options to purchase Common Stock are subject to the following vesting schedule - 1/5 vest on 5/30/2026, 1/5 vest on 5/30/2027, 1/5 vest on 5/30/2028, 1/5 vest on 5/30/2029 and 1/5 vest on 5/30/2030.
Remarks:
/s/John J. Feeney/attorney in fact05/21/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did RBC (RBC) director Steven H. Kaplan receive in this Form 4?

He received a grant of 344 shares of Common Stock and options for 647 shares. These awards are compensation-related and add to his existing restricted stock and stock option holdings in RBC Bearings.

Were there any open-market stock purchases or sales in this RBC (RBC) Form 4?

No open-market purchases or sales were reported. The filing shows compensation-related grants of restricted stock and stock options, plus updated holdings and vesting schedules, rather than discretionary buying or selling in the market.

How many restricted RBC (RBC) shares does Steven H. Kaplan hold after this filing?

He holds 1,728 shares of restricted Common Stock after the reported grant of 344 shares. These restricted shares vest in stages between 2026 and 2029 according to specific dates outlined in the footnotes.

What are the key terms of the new RBC (RBC) stock option grant?

Kaplan received options for 647 shares of Common Stock at an exercise price of $565.2200. These options vest in five equal annual installments from May 19, 2027, through May 19, 2031, and expire on May 19, 2033.

What other stock options are outstanding for Steven H. Kaplan at RBC (RBC)?

He holds several option positions with exercise prices from $137.4400 to $365.8700, covering underlying shares ranging from 400 to 1,000. These options expire between 2027 and 2032, with portions already exercisable and remaining parts vesting over future dates.

Does this RBC (RBC) Form 4 indicate any major change in Kaplan’s ownership?

The filing mainly reflects routine director compensation grants and updated vesting details. It increases his restricted stock and option holdings but does not show large discretionary market trades or a major reduction in his overall equity position.